Scroll Top
Gersthofer Straße 16 / Top 15, 1180 Wien

Publikationsliste

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.Rudler M, Hernández-Gea V, Procopet BD, Giráldez A, Amitrano L, Villanueva C, Ibañez L, Silva-Junior G, Genesca J, Bureau C, Trebicka J, Bañares R, Krag A, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Canete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernandez-Guerra M, Sassatelli R, Dell’era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Larrue H, Primignani M, Nevens F, Calleja JL, Schwarzer R, Jansen C, Robic MA, Conejo I, Martínez Gonzalez J, Catalina MV, Albillos A, Alvarado E, Guardascione MA, Mallet M, Tripon S, Casanovas G, Bosch J, Garcia-Pagan JC, Thabut D; for International Variceal Bleeding Observational Study Group: a Baveno Cooperation.Gut. 2023 Apr;72(4):749-758.
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.Schwarzer R, Reiberger T, Mandorfer M, Kivaranovic D, Hametner S, Hametner S, Paternostro R, Scheiner B, Schneeweiss-Friedl J, Schoefel R, Maieron A

J Gastroenterol. 2020 May;55(5):533-542.

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.Schwarzer R, Kivaranovic D, Paternostro R, Mandorfer M, Reiberger T, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Aliment Pharmacol Ther. 2018 Apr;47(8):1162-1169.

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension.Schwarzer R, Kivaranovic D, Mandorfer M, Paternostro R, Wolrab D, Heinisch B, Reiberger T, Ferlitsch M, Gerner C, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Aliment Pharmacol Ther. 2018 Jan;47(1):86-94.

Liver Biopsy-Transjugular.Schwarzer R, Ferlitsch A

Clin Liver Dis (Hoboken). 2014 Dec 9;4(5):113-115

 

Forty years without symptoms after choledochogastrostomy.

Schwarzer R, Tischer A, Dulic M, Dulic-Lakovic E, Assadi S, Gschwantler M.

Endoscopy. 2012;44 Suppl 2 UCTN:E199-200.

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.Martínez J, Hernández-Gea V, Rodríguez-de-Santiago E, Téllez L, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Genescà J, Bureau C, Trebicka J, Bañares R, Krag A, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha-Ferreira C, Cañete N, Rodríguez M, Ferlitsch A, Schwarzer R, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell Era A, Senzolo M, Abraldes JG, Romero-Gomez M, Zipprich A, Casas M, Masnou H, Primignani M, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Rudler M, Alvarado E, Perez-Campuzano V, Guardascione MA, Fischer P, Bosch J, García-Pagán JC, Albillos A; International Variceal Bleeding Observational Study Group and Baveno Cooperation.
J Hepatol. 2021 Apr 9:S0168-8278(21)00230-0.
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria.Pfisterer N, Schmidbauer C, Riedl F, Maieron A, Stadlbauer V, Hennlich B, Schwarzer R, Puespoek A, Bucsics T, Effenberger M, Bota S, Gschwantler M, Peck-Radosavljevic M, Mandorfer M, Madl C, Trauner M, Reiberger T.

Wien Klin Wochenschr. 2020 Dec 3.

Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.Paternostro R, Kapzan L, Mandorfer M, Schwarzer R, Benedikt S, Viveiros A, Bauer D, Ferlitsch M, Zoller H, Trauner M, Ferlitsch A.

J Gastroenterol Hepatol. 2020 Sep;35(9):1619-1627.

The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A.

Liver Int. 2019 Dec;39(12):2374-2385.

Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information.Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, Paternostro R, Scheiner B, Wöran K, Pinter M, Stättermayer AF, Trauner M, Peck-Radosavljevic M, Ferlitsch A, Reiberger T.

Dig Liver Dis. 2019 Aug;51(8):1144-1151.

Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis.Paternostro R, Heinisch BB, Reiberger T, Mandorfer M, Bardach C, Lampichler K, Seeland B, Schwarzer R, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Hepatol Res. 2019 Feb;49(2):201-211.

Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.Paternostro R, Heinisch BB, Reiberger T, Mandorfer M, Schwarzer R, Seeland B, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Liver Int. 2018 Aug;38(8):1427-1436.

Follow-up of sustained virologic responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.Kozbial K, Moser S, Al-Zoairy R, Schwarzer R, Datz C, Stauber R, Laferl H, Strasser M, Beinhardt S, Stättermayer AF, Gschwantler M, Zoller H, Maieron A, Graziadei I, Trauner M, Steindl-Munda P, Hofer H, Ferenci P.

Liver Int. 2018 Jun;38(6):1028-1035.

Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.Paternostro R, Wagner D, Reiberger T, Mandorfer M, Schwarzer R, Ferlitsch M, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

Wien Klin Wochenschr. 2017 Jan;129(1-2):8-15.

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with SVR following IFN-free DAA treatment.Kozbial K, Moser S, Schwarzer R, Laferl H, Al-Zoairy R, Stauber R, Stättermayer AF, Beinhardt S, Graziadei I, Freissmuth C, Maieron A, Gschwantler M, Strasser M, Peck-Radosalvjevic M, Trauner M, Hofer H, Ferenci P.

J Hepatol. 2016 Oct;65(4):856-858.

Endoscopic versus surgical management of biliary complications – Outcome analysis after 1188 orthotopic liver transplantations.Györi G, Schwarzer R, Puespoek A, Schoefl R, Silberhumer GR, Langer FB, Peck-Radosavljevic M, Berlakovich GA, Ferlitsch A.

Digestive and Liver Disease 2016 Nov;48(11):1323-1329.

Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension.Mandorfer M, Kozbial K, Schwabl P, Freissmuth C, Schwarzer R, Stern R, Chromy D, Stättermayer A, Reiberger T, Beinhardt S, Sieghart W, Trauner M, Hofer H, Ferlitsch A, Ferenci P, Peck-Radosavljevic M

J Hepat 2016 Oct;65(4):692-699.

Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.Paternostro R, Reiberger T, Mandorfer M, Schwarzer R, Schwabl P, Bota S, Ferlitsch M, Trauner M, Peck-Radosavljevic M, Ferlitsch A.

J Gastroenterol Hepatol. 2017 Jan;32(1):184-190.

Urological aspects in patients with liver cirrhosis.Friedl A, Schwarzer R, Schneeweiss J, Brössner C.

Urologe A. 2016 Jan;55(1):63-7.

Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses.Mandorfer M, Kozbial K, Freissmuth C, Schwabl P, Stättermayer AF, Reiberger T, Beinhardt S, Schwarzer R, Trauner M, Ferlitsch A, Hofer H, Peck-Radosavljevic M, Ferenci P.

Aliment Pharmacol Ther. 2015 Sep;42(6):707-18.

Liver transplantation reverses hypergammaglobulinemia in patients with chronic hepatic failure.Lebherz-Eichinger D, Schwarzer R, Motal MC, Klaus DA, Mangold A, Ankersmit HJ, Berlakovich GA, Krenn CG, Roth GA.

Biochem Med. 2015 Jun 5;25(2):252-61

Performance of 2-D shear wave elastography in liver fibrosis assessment compared with serologic tests and transient elastography in clinical routine.Bota S, Paternostro R, Etschmaier A, Schwarzer R, Salzl P, Mandorfer M, Kienbacher C, Ferlitsch M, Reiberger T, Trauner M, Peck-Radosavljevic M, Ferlitsch

Ultrasound Med Biol. 2015 Sep;41(9):2340-9.

Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.Ferlitsch A, Bota S, Paternostro R, Reiberger T, Mandorfer M, Heinisch B, Salzl P, Schwarzer R, Sieghart W, Peck-Radosavljevic M, Ferlitsch M.

Liver Int. 2015 Sep;35(9):2115-20.

Lower urinary tract symptoms in patients with liver cirrhosis.Margreiter M, Heinisch BB, Schwarzer R, Klatte T, Shariat SF, Ferlitsch A.

World J Urol. 2015 Mar;33(3):315-21

Increased levels of serum amyloid A during the early phase of hepatitis C treatment with interferon are associated with sustained virologic response – a pilot study.Gschwantler M, Dulic M, Dulic-Lakovic E, Schwarzer R, Rieder F, Graninger W, Steininger C.

J Gastrointestin Liver Dis. 2014 Mar;23(1):101-2

Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients.Scherzer TM, Stättermayer AF, Stauber R, Maieron A, Strasser M, Laferl H, Schwarzer R, Datz C, Rutter K, Beinhardt S, Munda P, Hofer H, Ferenci P.

J Hepatol. 2013 Nov;59(5):964-71

Transesophageal echocardiography during orthotopic liver transplantation in patients with esophagoastric varices.Burger-Klepp U, Karatosic R, Thum M, Schwarzer R, Fuhrmann V, Hetz H, Bacher A, Berlakovich G, Krenn CG, Faybik P.

Transplantation. 2012 Jul 27;94(2):192-6

Internist und Leberspezialist Dr. Remy Schwarzer am Rednerpult bei einem Kongress
Cookies
Bei Ihrem Besuch unserer Website können Informationen über Ihren Besuch über Ihren Browser in Form von Cookies an einzelne Systeme weitergegeben werden. Sie können hier Ihre Einstellungen zu den Cookies anpassen. Bitte beachten Sie, dass damit vielleicht einige Funktionen der Website beeinträchtigt werden.